SEC Form 4 · accession 0001209191-18-046294
ARATANA THERAPEUTICS, INC. · PETX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ernst Heinen
Officer — Chief Development Officer
Period of report
Aug 8, 2018
Accepted (ET)
Aug 10, 2018 · 5:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001509190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 8, 2018 | S | 2,674 | $5.15 | D | 168,020 | D | |
| Common Stock | Aug 10, 2018 | S | 1,954 | $5.15 | D | 166,066 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.